Clinical Trials Logo

Autistic Disorder clinical trials

View clinical trials related to Autistic Disorder.

Filter by:

NCT ID: NCT05523895 Recruiting - Clinical trials for Irritability Associated With Autism Spectrum Disorder

Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder

Start date: August 9, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

6-week, randomized, double-blind, fixed-dose, placebo-controlled, parallel group study in children and adolescents (aged 5 to17 years) with autism spectrum disorder (ASD) with irritability, agitation, or self-injurious behaviors to study the efficacy and safety of pimavanserin

NCT ID: NCT05520632 Recruiting - Clinical trials for Autism Spectrum Disorder

Autism Spectrum Disorder: BAEPs Findings and Behavioral Responses to Sounds

Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

There are many studies in the literature that study the sensory profile of children with autism spectrum disorder (ASD), which can essentially have three types of behavior: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding. However, there are few studies dedicated to the study of the sensory profile of children with autism. A child's sensory profile is closely related to the way they deal with the world and their social interaction. The existence of tools that allow the study of the behavioral response to the sounds of children with autism spectrum disorder, will allow the application of targeted therapies in the future. Therapies targeted and adjusted to each profile observed in these children will allow to attenuate these maladjusted behavioral responses, or even overcome these deficits, if there is an early and precise intervention.

NCT ID: NCT05516407 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.

Start date: April 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a 20-week open-label study to evaluate the safety and efficacy of full-spectrum medicinal cannabis plant extract < 0.08% THC (FEN164) in children with Autism Spectrum Disorder.

NCT ID: NCT05515913 Completed - Clinical trials for Autistic Spectrum Disorder

Nutritional Status and ASD Severity of Autistic Spectrum Disorder Children in Addis Ababa, Ethiopia; Case Control Study

ASD
Start date: August 14, 2021
Phase:
Study type: Observational

The study conducts a case control analysis of the nutritional status and intake of autistic spectrum disorder diagnosed children as compared to typically developing children in Addis Ababa, Ethiopia. It included analysis of anthropometric measurements, three days food diary food intake, urinary iodine analysis, childhood autism rating scale diagnosis, food frequency and eating behavior questioner and proximate analysis of one day major meals of selected subjects.

NCT ID: NCT05512637 Not yet recruiting - Clinical trials for Autism Spectrum Disorder

Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers

FRATSA
Start date: November 2022
Phase:
Study type: Observational [Patient Registry]

In this study, a selective and multi-stages screening for neurodevelopmental disorders (NDD) in siblings of children with a confirmed ASD is done. The main aims are to estimate the prevalence of NDD among siblings and to evaluate the feasibility and acceptability of a standardized screening procedure.

NCT ID: NCT05512221 Recruiting - Clinical trials for GBAT+Engagement Booster

Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics

(GBAT+)
Start date: September 23, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to build upon an earlier study that evaluated the use of a 10-week transdiagnostic Group Behavioral Activation Therapy (GBAT), a telehealth delivered intervention, as a cost effective and accessible way to treat symptoms of anxiety and depression in autistic adults. The current study will pilot and compare relative feasibility, acceptability, and preliminary efficacy of three adapted GBAT groups and a Watchful Waiting (WW) group. The three groups include GBAT+Individual (GBAT+I; individual sessions to supplement the 10 group sessions), GBAT+Engagement Booster (GBAT+E; supplemental materials), and GBAT+Both (GBAT+IE individual sessions and supplemental materials).

NCT ID: NCT05511220 Recruiting - Clinical trials for Autism Spectrum Disorder With Impaired Functional Language

Pivotal Response Intervention Minimal Responders Study

PRIMeR
Start date: July 12, 2022
Phase: N/A
Study type: Interventional

Early intervention (EI) using naturalistic behavioural methods have shown benefits for the development of communication and other skills for young children with autism spectrum disorder. The publicly funded autism EI program in Nova Scotia (NS) is based on such a method, Pivotal Response Treatment (PRT), and pre-post studies indicate benefits for children and families. However, not all children benefit equally. In this study, the investigators test the efficacy of a brief parent-mediated intervention designed to prime responsivity to PRT in children with a minimal responder profile derived from previous studies of the PRT-based EI program.

NCT ID: NCT05509309 Recruiting - Clinical trials for Autism Spectrum Disorder

Promoting Inclusive Educational Environments for Children With Autism and Other Social-communication Challenges: Preschool Class and Primary School

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

This study evaluates the effect of using the Autism Program Environment Rating Scale (APERS) as the foundation for providing feedback, in-service training and coaching to teachers, to improve program quality for autistic (ASD) students and students with related social-communication challenges (SCC) in Swedish primary school classrooms. In the current study half of the participating classrooms will receive the APERS-based model for program quality improvement, while the other half will receive services as usual. It is hypothesized that the APERS-based model will improve primary school program quality for children with ASD and SCC, as well as improve functioning for students with ASD/SCC and self-perceived self-efficacy among participating teachers, compared to the study's comparison group.

NCT ID: NCT05503459 Completed - Clinical trials for Cognitive Impairment

Exercise and Cognition in Children With ASD

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Physical exercise is widely reported to be beneficial to executive functions (EFs) in children with autism spectrum disorder (ASD). However, the impact of physical exercise on self-regulation (SR) in this population remains unknown. Moreover, very few studies have been done to examine the mechanism(s) that underlie the exercise-EF and exercise-SR relationships. The purposes of the present study were to test whether two types of physical exercise (cognitively engaging vs. non-cognitively engaging) benefited SR, and if the social, emotional and physical needs of an individual mediated the exercise-EF and exercise-SR relationships. Children diagnosed with ASD were randomly assigned into one of three groups: learning to ride a bicycle (n = 23), stationary cycling (n = 19) or an active control with walking (n = 22). Two EFs (flexibility and inhibition), SR and the mediating roles of perceived social support, enjoyment, stress, physical self-efficacy and perceived physical fitness were assessed.

NCT ID: NCT05502484 Enrolling by invitation - Clinical trials for Autism Spectrum Disorder

Development of Self-regulation by Dialectial Behavioural Therapy in Adults With Autism

DASHBOARD
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Individuals with autism spectrum disorder (ASD) are at risk to develop more pervasive emotion-dysregulation. In this study experiences of adults with ASD and severe emotion dysregulation with Integrative Dialectical Behaviour Therapy (DBT) and the mechanisms and processes that hinder and advance the pathway to recovery will be studied, in order to make the treatment more tailored and effective for this target group.